Enhanced External Counterpulsation Effects on Venous Leg Symptoms

Overview

Journal Anatol J Cardiol

Publisher Kare Publishing

Specialty Cardiology & Vascular Diseases

Date 2022 May 13

PMID 35552177

Authors

Bilal Cuglan

Hasan Turhan

Ertan Yetkin

Affiliations

Soon will be listed here.

Abstract

Background: Venous diseases encompass a large spectrum of abnormalities in the venous system with complaints, such as aching and swelling. Enhanced external counterpulsa-tion, proven safe and effective in patients with coronary artery disease and chronic heart failure, is a technique that increases venous return and augments diastolic blood pres-sure. This study assessed the effects of enhanced external counterpulsation on symp-toms of venous disease using the Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms questionnaire.

Methods: This study was designed prospectively for evaluating venous symptoms before and after enhanced external counterpulsation treatment. The study population con-sisted of 30 consecutive patients who were admitted to the cardiology clinic. The Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms ques-tionnaire was applied to assess venous symptoms one day before and after enhanced external counterpulsation treatment.

Results: The mean age of the patients was 64.62 ± 9.67 years. After 35 hours of enhanced external counterpulsation, 28 patients (93%) had at least 1 New York Heart Association functional class reduction compared with baseline and 43% of patients had 2 New York Heart Association functional classes improvement. The New York Heart Association class significantly decreased after enhanced external counterpulsation treatment (P<.001). There was a significant improvement in their swelling and night cramps symptoms compared with baseline (P< .001 and P = .05, respectively). Also, The left ventricular ejec-tion fraction significantly increased after the enhanced external counterpulsation treat- ment (P = .02).

Conclusions: The findings obtained in the present study suggested that patients treated with enhanced external counterpulsation showed a significant reduction in swelling and night cramps symptoms. Although the total VEIN score did not change after the enhanced external counterpulsation procedure, improvement in swelling and night cramps under-lines the beneficial effects of enhanced external counterpulsation through the venousvascular territory.

References

Soran O, Ikizler C, Sengul A, Cuglan B, Kennard E, Kelsey S . Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey. Turk Kardiyol Dern Ars. 2012; 40(4):323-30. DOI: 10.5543/tkda.2012.59144. View

Braith R, Conti C, Nichols W, Choi C, Khuddus M, Beck D . Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation. 2010; 122(16):1612-20. PMC: 2963100. DOI: 10.1161/CIRCULATIONAHA.109.923482. View

Lund L, Claggett B, Liu J, Lam C, Jhund P, Rosano G . Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail. 2018; 20(8):1230-1239. DOI: 10.1002/ejhf.1149. View

Amin F, Al Hajeri A, Civelek B, Fedorowicz Z, Manzer B . Enhanced external counterpulsation for chronic angina pectoris. Cochrane Database Syst Rev. 2010; (2):CD007219. PMC: 7180079. DOI: 10.1002/14651858.CD007219.pub2. View

Solomon S, Claggett B, Lewis E, Desai A, Anand I, Sweitzer N . Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur Heart J. 2015; 37(5):455-62. PMC: 4751235. DOI: 10.1093/eurheartj/ehv464. View

Kutlu A, Yilmaz E, Cecen D, Eser E, Ozbakkaloglu A . The Turkish validity and reliability of the venous insufficiency epidemiological and economic study-quality of life/symptoms scales. Angiology. 2011; 62(4):329-37. DOI: 10.1177/0003319710394159. View

Thakkar B, Hirsch A, Satran D, Bart B, Barsness G, McCullough P . The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease. Vasc Med. 2009; 15(1):15-20. DOI: 10.1177/1358863X09106549. View

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36):3599-3726. DOI: 10.1093/eurheartj/ehab368. View

Nicolaides A, Labropoulos N . Burden and Suffering in Chronic Venous Disease. Adv Ther. 2019; 36(Suppl 1):1-4. PMC: 6824337. DOI: 10.1007/s12325-019-0882-6. View

10.

Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T . Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001; 37(1):93-9. DOI: 10.1016/s0735-1097(00)01095-0. View

11.

Yang D, Wu G . Vasculoprotective properties of enhanced external counterpulsation for coronary artery disease: beyond the hemodynamics. Int J Cardiol. 2012; 166(1):38-43. DOI: 10.1016/j.ijcard.2012.04.003. View

12.

Michaels A, Linnemeier G, Soran O, Kelsey S, Kennard E . Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]). Am J Cardiol. 2004; 93(4):461-4. DOI: 10.1016/j.amjcard.2003.10.044. View

13.

Soran O, Kennard E, Bart B, Kelsey S . Impact of external counterpulsation treatment on emergency department visits and hospitalizations in refractory angina patients with left ventricular dysfunction. Congest Heart Fail. 2007; 13(1):36-40. DOI: 10.1111/j.1527-5299.2007.05989.x. View

14.

Yetkin E, Ozturk S . Dilating Vascular Diseases: Pathophysiology and Clinical Aspects. Int J Vasc Med. 2018; 2018:9024278. PMC: 6129317. DOI: 10.1155/2018/9024278. View

15.

Arora R, Chou T, Jain D, Fleishman B, Crawford L, McKiernan T . The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999; 33(7):1833-40. DOI: 10.1016/s0735-1097(99)00140-0. View

16.

Abdul-Rahim A, Shen L, Rush C, Jhund P, Lees K, McMurray J . Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Eur J Heart Fail. 2018; 20(7):1139-1145. DOI: 10.1002/ejhf.1160. View

17.

Braith R, Casey D, Beck D . Enhanced external counterpulsation for ischemic heart disease: a look behind the curtain. Exerc Sport Sci Rev. 2012; 40(3):145-52. PMC: 3383356. DOI: 10.1097/JES.0b013e318253de5e. View

18.

Michaels A, Accad M, Ports T, Grossman W . Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation. 2002; 106(10):1237-42. DOI: 10.1161/01.cir.0000028336.95629.b0. View

19.

Martin J, Beck D, Aranda Jr J, Braith R . Enhanced external counterpulsation improves peripheral artery function and glucose tolerance in subjects with abnormal glucose tolerance. J Appl Physiol (1985). 2011; 112(5):868-76. DOI: 10.1152/japplphysiol.01336.2011. View

20.

Solomon S, McMurray J, Anand I, Ge J, Lam C, Maggioni A . Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019; 381(17):1609-1620. DOI: 10.1056/NEJMoa1908655. View